We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+10.35%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$113M
AUM Growth
-$2.14M
(-1.9%)
Cap. Flow
-$5.51M
Cap. Flow
% of AUM
-4.87%
Top 10 Holdings %
Top 10 Hldgs %
14.17%
Holding
280
New
34
Increased
61
Reduced
100
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Financials Index ETF
FNCL
|
+$1.46M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.13M |
| 3 |
MediciNova
MNOV
|
+$969K |
| 4 |
ADVM
Adverum Biotechnologies
ADVM
|
+$866K |
| 5 |
CLSD
Clearside Biomedical
CLSD
|
+$856K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Information Technology Index ETF
FTEC
|
+$2.78M |
| 2 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
+$1.32M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
+$1.22M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$1.01M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
+$938K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.9% |
| 2 | Financials | 0.8% |
| 3 | Technology | 0.58% |
| 4 | Consumer Discretionary | 0.4% |
| 5 | Energy | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Micron Technology
MU
$1.04T
| $49K | 0.04% |
934
+54
| +6% | +$2.92K |
|
152
Televisa
TV
$1.45B
| $48K | 0.04% |
2,552
-738
| -22% | -$13K |
|
153
CVS Health
CVS
$137B
| $46K | 0.04% |
715
+46
| +7% | +$3.03K |
|
|
ESRX
154
DELISTED
Express Scripts Holding Company
ESRX
| $46K | 0.04% |
598
| – | – |
|
155
HP
HPQ
$23.5B
| $45K | 0.04% |
1,980
-123
| -6% | -$2.74K |
|
156
Home Depot
HD
$332B
| $44K | 0.04% |
226
| – | – |
|
157
Netflix
NFLX
$292B
| $43K | 0.04% |
1,090
-80
| -7% | -$2.73K |
|
158
NetEase
NTES
$76.5B
| $43K | 0.04% |
850
-65
| -7% | -$3.32K |
|
159
Valero Energy
VLO
$89.8B
| $41K | 0.04% |
371
| – | – |
|
160
Pfizer
PFE
$140B
| $37K | 0.03% |
1,076
| – | – |
|
161
Broadcom
AVGO
$1.82T
| $35K | 0.03% |
1,450
-180
| -11% | -$4.41K |
|
162
ICICI Bank
IBN
$106B
| $35K | 0.03% |
4,338
-640
| -13% | -$5.49K |
|
163
Cemex
CX
$17.4B
| $34K | 0.03% |
5,137
-1,580
| -24% | -$9.99K |
|
164
Progressive
PGR
$124B
| $33K | 0.03% |
553
-43
| -7% | -$2.63K |
|
|
EMBJ
165
Embraer S.A. ADS
EMBJ
$11.6B
| $32K | 0.03% |
1,270
+677
| +114% | +$17.2K |
|
166
Altria Group
MO
$122B
| $32K | 0.03% |
564
| – | – |
|
167
Centene
CNC
$31.3B
| $30K | 0.03% |
492
+52
| +12% | +$3K |
|
168
IBM
IBM
$202B
| $30K | 0.03% |
227
+32
| +16% | +$4.46K |
|
169
Cigna
CI
$76.6B
| $28K | 0.02% |
162
-41
| -20% | -$7.1K |
|
170
Capital One
COF
$124B
| $28K | 0.02% |
304
| – | – |
|
171
EOG Resources
EOG
$78B
| $28K | 0.02% |
225
| – | – |
|
172
F5
FFIV
$22.1B
| $28K | 0.02% |
163
+65
| +66% | +$10.8K |
|
173
Gerdau
GGB
$9.44B
| $28K | 0.02% |
10,109
+5,633
| +126% | +$19.6K |
|
174
Eli Lilly
LLY
$1.07T
| $28K | 0.02% |
328
+35
| +12% | +$2.88K |
|
175
PepsiCo
PEP
$186B
| $28K | 0.02% |
256
| – | – |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
ALS
Virtus ETF Advisers's Q2 2018 Portfolio in Review
As of Q2 2018, Virtus ETF Advisers held 280 positions worth $113M, down 1.9% from $115M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Virtus ETF Advisers withdrew a net $5.51M in Q2 2018, closing 19 positions and reducing 100 holdings. Its most notable exit was Jounce Therapeutics, Inc. Common Stock, an estimated $1.32M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 79% a quarter earlier, followed by Financials and Technology.
Against the trend, Virtus ETF Advisers opened a new position in Fidelity MSCI Financials Index ETF worth $1.41M.
- Virtus ETF Advisers's largest Q2 2018 buy was Fidelity MSCI Financials Index ETF: 35,927 shares worth $1.41M.
- Virtus ETF Advisers added most to iShares 20+ Year Treasury Bond ETF in Q2 2018, an estimated $1.13M increase.
- Virtus ETF Advisers's biggest Q2 2018 reduction was Fidelity MSCI Information Technology Index ETF, cutting an estimated $2.78M.
- Virtus ETF Advisers fully exited Jounce Therapeutics, Inc. Common Stock in Q2 2018, selling an estimated $1.32M.
- Virtus ETF Advisers's ten largest holdings make up 14% of its $113M portfolio in Q2 2018.
- Virtus ETF Advisers opened 34 new positions and closed 19 in Q2 2018.
- Virtus ETF Advisers's portfolio value fell 1.9% quarter-over-quarter to $113M.
Based on Virtus ETF Advisers's 13F filing for Q2 2018, filed 10 Aug 2018.